I thought Trudeau just announced that he all but eliminated poverty in Canada.
WELL SURE!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
THE PROBLEM IS THAT OUR IDIOT BOY HAS DECIDED THAT PEOPLE WHO LIVE IN PLACES
WHERE CONSERVATIVES GET LOTS OF VOTES.................................
HAVE SOMEHOW RENOUNCED CDN CITIZENSHIP!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
AND THUS CONSERVATIVES AINT CDNS........................................
AND THEY DONT DESERVE TO BE COUNTED!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
AND THEY CAN BE LEFT TO STARVE!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Here is an article that will resonate with anybody who is convinced that “no name brands” are generally inferior to name brands - and that LIE-beral gravy grabbing is compromising the health of Cdns!! With some comments of my own in brackets):
'Back at square one:' B.C. Crohn's patient struggles with forced transition to biosimilar medication
More than 12,000 people in B.C. have switched to biosimilar medications since the province announced it would stop funding name brand three drugs
By Glenda Luymes , Vancouver Sun
Published February 10, 2020
For 10 years, Debbie Aschwanden managed the symptoms of Crohn’s disease with a drug called Remicade.
When the provincial government announced it would no longer fund the drug through Pharmacare, she and about 1,700 patients with inflammatory bowel disease were told to switch to a less-expensive copycat drug before March 5.
For two months after she switched, the Williams Lake insurance broker struggled with “horrible” symptoms that felt like a Crohn’s flare-up or a bad flu.
“I was super sick,” said Aschwanden, who has a 13-year-old son. “I had to miss a few days of work even though I tried to push through.”
(It is bad enough to compare no name coffee and other products to their name brand counterparts- how much worse must it be to KNOW that no name brands are NOT preventing your illness!! This switch to low cost and apparently often less effective no name brands is yet another sneaky way for govt to offload health care costs and build up a TWO TIER HEALTH CARE SYSTEM - meaning if you want the good drugs - buy them yourself - if you can!!!!!!!!!!!!!!!!!!!!)
(Civil service union HOGS and other specially PRIVILEGED GROUPS are insisting that the govt move to a more fully “user pay” health system - which would mean that HOGS would continue getting better drug benefits and etc than the rest of us - paid for by union benefits not available to ordinary Cdns - who could NOT AFFORD to get that better service HOGS DEMAND!!!!!!!!!!!!!!)
(It is bad enough that NO HOG working for any of our FOUR LEVELS of govt in Ontari-owe ever pays a penny of the McGinty LIE-beral health “levy” - all HOGS get it paid for as one of their govt mandated ENTITLEMENTS!! Yet HOGS - as always WANT MORE - they do not wish to line up for rationed health care like the rest of us!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!)
She switched to Inflectra first, one of the two biosimilar drugs indicated by the government to replace Remicade. After two infusions, her doctor switched her to another biosimilar called Renflexis, hoping for a better result. So far, she hasn’t had the same symptoms, but she isn’t feeling as healthy as she did while on the original biologic drug.
“After I was diagnosed (with Crohn’s), I was so thankful to find something that helped,” she said. “To have that ripped from under me was really tough. It was like I was back at square one.”
Crohn’s patients were part of a second group of British Columbians who were required to transition their prescriptions to a biosimilar equivalent beginning last year.
In September, the government announced gastroenterology patients across B.C. would have six months to switch their prescription from Remicade to Inflectra or Renflexis.
(One has to ask if govt would be willing to pay a PORTION of the cost of the name brand drug - with the patient picking up part of the tab????????)
The news followed a similar announcement in May, when B.C. became the first Canadian province to stop funding three injectable drugs, including Lantus, Ebrel and Remicade, for non-gastroenterology patients. An estimated 20,000 patients were given until Nov. 25 to switch to biosimilar drugs for diabetes, rheumatoid arthritis, plaque psoriasis and several other chronic conditions.
Coverage for the original drugs would only be provided in exceptional cases, decided on a case-by-case basis.
Biosimilars are similar to generic drugs in that they are manufactured after the 20-year patent expires on the original biologics. But they cost 25 to 50 per cent less than the original.
(You get what you pay for- low price equals LOWER QUALITY MAYBE??????)
According to the B.C. Ministry of Health, the province spent $125 million on the three biologic drugs affected by the policy change in 2018, including $84.2 million on Remicade. Since Remicade was approved for sale by the federal government in 2001, the province has spent more than $671 million.
“We know that the use of biosimilars in other countries has worked extremely well in ensuring people get the medication they need, and it’s time we caught up,” Health Minister Adrian Dix said at a news conference in September. “By using biosimilars in B.C., we will be putting about $96.6 million back into health care over the next three years.”
(Uh huh- biosimilars DO “work extremely well” in cutting govt costs -clearly that is the PRIMARY LIE-beral focus!!!!!!!!!!!!!!!!!!!!!)
But critics said the financial gains don’t offset the hardship experienced by patients who are sensitive to prescription changes.
“We’ve heard of dozens and dozens of challenges experienced by people in B.C.,” said Mina Mawani, president and CEO of Crohn’s & Colitis Canada.
She said the charity is aware of 140 Crohn’s patients who have applied for an exemption to receive coverage for Remicade, but only two have been approved. Among those denied was a person with Stage 4 cancer who also has Crohn’s disease and someone with a complex history of anxiety. Several nursing mothers are waiting to hear if their exemption requests will be approved.
(I guess LIE-berals figure the dying stage 4 cancer patient is already suffering enough that it would be CRUEL to subject them to bowel disease as well????????)
“I feel disheartened,” said Mawani. “We’ve been told that patients are simply being emotional about switching. But we know they’re not emotional. This is their life.”
She said Crohn’s & Colitis Canada believes biosimilars are a safe and effective treatment for people with inflammatory bowel disease, but patients and doctors should have a choice.
(No doubt biosimilars ARE SAFE - but anybody who has used a no name brand and then compared it to a premium brand KNOWS there is a USUALLY a quality difference!!!!!!!!!!!!!!!!!!!)
“The issue is not about starting new patients on the biosimilar drugs. It’s about the government forcing people who are stable to make the switch. What does that do to their health, including their mental health?”
Mawani said the government isn’t able to answer that question because it is not adequately tracking the impact of the switch on individual patients.
(Gosh - no LIE-beral tracking?? Why would they want to have such information that might prove BADLY EMBARRASSING?? And no doubt DOSAGE levels have an influence as well???????)
The Ministry of Health was unable to provide answers to questions about outcomes for people with Crohn’s disease or the number of exceptional requests it has received. Material on its website says B.C. spent nine years studying biosimilars before announcing the switch, consulting with a wide variety of physician and patient groups, as well as regional health authorities and Health Canada.
Figures provided by the Ministry of Health shows that as of Dec. 31, 55 per cent of B.C. patients on Lantus had switched to a biosimilar, while 78 per cent on Enbrel and 73 per cent on Remicade for non-gastrointestinal issues had switched, for a total of 11,930 patients.
Gastroenterology patients were given until March 5 to transition from Remicade to Inflectra or Renflexis. As of Dec. 31, 28 per cent, or 529 people out of 1,858, had switched.
Not everyone is upset about biosimilars, with many B.C. doctors and scientists in favour of them. As a result of the savings, diabetics now receive coverage for an additional drug, Jardiance, which doctors had long advocated.
(Oh - LIE-berals have apparently decided there are more votes to be bought by sucking up to Diabetic patients than Crohns and Colitis sufferers!!!!!!!!!!!!!!!!!!!)
Dix said he made the switch to a 15 per cent cheaper biosimilar to treat his Type 1 diabetes and there were no negative effects.
(That`s nice- but others report much more NEGATIVE RESULTS from biosimilars - with LIE-berals refusing to track the results!!!!!!!!!!!!!!!!!)